BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Down 90.9% in March

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 200 shares, a decline of 90.9% from the February 29th total of 2,200 shares. Based on an average daily volume of 2,700 shares, the short-interest ratio is currently 0.1 days.

BioSyent Stock Performance

Shares of OTCMKTS:BIOYF traded down $0.04 during trading on Thursday, reaching $6.38. 2,350 shares of the company traded hands, compared to its average volume of 3,207. BioSyent has a 52-week low of $5.26 and a 52-week high of $6.97. The business’s fifty day moving average is $6.38 and its 200-day moving average is $6.21.

BioSyent Increases Dividend

The company also recently disclosed a dividend, which was paid on Friday, March 15th. Shareholders of record on Thursday, February 29th were issued a $0.0332 dividend. This is an increase from BioSyent’s previous dividend of $0.03. The ex-dividend date of this dividend was Wednesday, February 28th. This represents a yield of 2.08%.

About BioSyent

BioSyent Inc, through its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.